Ensure greater transparency and meaningful participation for a better pandemic accord
This statement was delivered by Medicines Law & Policy at the Intergovernmental Negotiating Body (INB), Session 12 (resumed), 6 December 2024
Madam co-chair (s), members...
Pandemic treaty must ensure timely access to technology and know-how
This statement was delivered by Medicines Law & Policy at the Intergovernmental Negotiating Body (INB), Session 12 (resumed), 4 December 2024
Thank you, co-chairs. We...
Transfer of Technology: New definition and stronger language needed
Statement by Medicines Law & Policy on Article 11, Technology Transfer Intergovernmental Negotiating Body on a Pandemic Accord (INB), Session 12
Delivered at the WHO on...
Getting to a meaningful agreement: ML&P’s opening statement to the 12th round of pandemic...
Thank you for giving us the opportunity to address the opening session of the INB12.
We would like to make the following points:
A pandemic agreement...
The new IP strategy of war-torn Ukraine should prioritise public health and national security
Russia’s full-scale assault on Ukraine continues for the third year. The Russian occupation forces have already killed tens of thousands of civilians, including children. They have...
Continuing to ignore the problem of the know-how gap won’t make it go away.
The Covid-19 pandemic was a wake-up call for a variety of issues in access to medicines, one of which was finding a solution to...
Pressure from European countries related to the use of TRIPS Flexibilities
The draft text of the World Health Organization pandemic accord reaffirms countries' rights to use to the full the flexibilities contained in the World...
The last mile: A few suggestions for the WHO Pandemic Agreement’s last two weeks...
This technical briefing note is also available as a PDF here.
On 16 April, the Bureau of the Intergovernmental Negotiating Body (INB) to draft and...
US Authorisation of Non-Voluntary Use of Patents frequently used for health technologies
During the Covid-19 pandemic, the United States prioritised the rapid development of products needed to combat the health crisis. Rapid product development was pursued...
European Parliament’s amendments make the Regulation for EU-wide compulsory licensing difficult to use and...
European Parliament legislative resolution of 13 March 2024, on the proposal for a regulation of the European Parliament and of the Council on compulsory...